Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes

  • Zeinali, Majid (Immunology Laboratory, Institute of Biochemistry and Biophysics, Universityof Tehran) ;
  • Ardestani, Sussan K. (Immunology Laboratory, Institute of Biochemistry and Biophysics, Universityof Tehran) ;
  • Kariminia, Amina (Department of Immunology, Pasteur Institute of Iran)
  • Published : 2007.12.31

Abstract

The identification and characterization of antigens that elicit human T cell responses is an important step toward understanding of Leishmania major infection and ultimately in the development of a vaccine. Micropreparative SDS-PAGE followed by electro transfer to a PVDF membrane and elution of proteins from the PVDF, was used to separate 2 novel proteins from L. major promastigotes, which can induce antibodies of the IgG2a isotype in mice and also are recognized by antisera of recovered human cutaneous leishmaniasis subjects. Fractionation of the crude extract of L. major revealed that all detectable proteins of interest were present within the soluble Leishmania antigens (SLA). Quantitation of these proteins showed that their expression in promastigotes is relatively very low. Considering the molecular weight, immunoreactivity, chromatographic and electrophoretic behavior in reducing and non-reducing conditions, these proteins are probably 2 isoforms of a single protein. A digest of these proteins was resolved on Tricine-SDS-PAGE and immunoreactive fragments were identified by human sera. Two immunoreactive fragments (36.4 and 34.8 kDa) were only generated by endoproteinase Glu-C treatment. These immunoreactive fragments or their parent molecules may be ideal candidates for incorporation in a cocktail vaccine against cutaneous leishmaniasis.

Keywords

References

  1. Ames GF, Nikaido K (1976) Two-dimentional gel electrophoresis of membrane proteins. Biochemistry 15: 616- 623 https://doi.org/10.1021/bi00648a026
  2. Gumy A, Louis JA, Launois P (2004) The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in the cell differentiation in mice from different genetic background. Int J Parasitol 34: 433-444 https://doi.org/10.1016/j.ijpara.2003.11.021
  3. Heinzel FP, Sadick MD, Mutha SS, Locksley RM (1991) Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4 lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 88: 7011-7015
  4. Helmut B (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gel. Electrophoresis 8: 93-97 https://doi.org/10.1002/elps.1150080203
  5. Iborra S, Soto M, Carrion J, Alonso C, Requena JM (2004) Vaccination with a plasmid DNA encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniasis. Vaccine 22: 3865-3876 https://doi.org/10.1016/j.vaccine.2004.04.015
  6. Kyhse-Andersen J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10: 203-209 https://doi.org/10.1016/0165-022X(84)90040-X
  7. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685 https://doi.org/10.1038/227680a0
  8. Lange UG, Mastroeni P, Blackwell JM, Stober CB (2004) DNA-Salmonella enterica serovar. typhimurium primerbooster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice. Infect Immun 72: 4924-4928 https://doi.org/10.1128/IAI.72.8.4924-4928.2004
  9. Mohammadi MR, Zeinali M, Ardestani SK, Kariminia A (2006) Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice. Korean J Parasitol 44: 43-48 https://doi.org/10.3347/kjp.2006.44.1.43
  10. Oakley BR, Kirsch DR, Morris NR (1980) A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105: 361-63 https://doi.org/10.1016/0003-2697(80)90470-4
  11. Papadopoulou G, Karagouni E, Dotsika E (1998) ISCOMs vaccine against experimental leishmaniasis. Vaccine 16: 885-891 https://doi.org/10.1016/S0264-410X(97)00308-3
  12. Sacks D, Anderson C (2004) Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol Rev 201: 225-238 https://doi.org/10.1111/j.0105-2896.2004.00185.x
  13. Sandermann H Jr, Strominger JL (1972) Purification and properties of C55-isoprenoid alcohol phosphokinase from staphylococcus aureus. J Biol Chem 247: 5123-5131
  14. Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368-379 https://doi.org/10.1016/0003-2697(87)90587-2
  15. Shimizu Y, Yamakami K, Gomi T, Nakata M, Asanuma H, Tadakuma T, Kojima N (2003) Protection against Leishmania major infection by oligomannose-coated liposomes. Bioorg Med Chem 11: 1191-1195 https://doi.org/10.1016/S0968-0896(02)00644-2
  16. Simpson RJ, Ward LD, Reid GE, Batterham MP, Moritz RL (1989) Peptide mapping and internal sequencing of proteins electroblotted from two-dimentional gels onto polyvinylidene difluoride membranes. A chromatographic procedure for separating proteins from detergents. J Chromatogr 476: 345-361 https://doi.org/10.1016/S0021-9673(01)93881-6
  17. Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG (1998) LeIF: A recombinant Leishmania protein that induces an IL-12- mediated Th1 cytokine profile. J Immunol 161: 6171- 6179
  18. Snapper CM, Paul WE (1987) Interferon gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947 https://doi.org/10.1126/science.3107127
  19. Tewary P, Sukumaran B, Saxena S, Madhubala R (2004) Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen. Vaccine 22: 3053-3060 https://doi.org/10.1016/j.vaccine.2004.02.007